AIMS/HYPOTHESIS: We have previously reported a high prevalence of non-alcoholic fatty liver disease (NAFLD) among women with previous gestational diabetes mellitus (pGDM). We wanted to confirm that intrahepatocellular lipid (IHCL) is associated with pGDM independently of adiposity and determine: (1) if VLDL metabolism is dysregulated; and (2) the extent to which NAFLD and IHCL account for the dysmetabolic phenotype in pGDM. METHODS: We analysed data from a cohort of 234 women (114 with pGDM) and identified effects of pGDM on lipid and glucoregulation that were independent of ultrasound-diagnosed NAFLD. We then measured IHCL by MR spectroscopy in a representative subgroup (n = 36) and conducted detailed metabolic studies (IVGTT, VLDL apolipoprotein B [apoB] kinetics and palmitate turnover) and measurement of regional body fat by MRI to demonstrate effects of IHCL that were independent of a history of pGDM. RESULTS: pGDM was associated with increased IHCL (p = 0.04) after adjustment for adiposity. Independently of IHCL, pGDM was associated with a lower IVGTT disposition index (p = 0.02) and acute insulin response to glucose (pGDM+/NAFLD-, 50% lower; pGDM+/NAFLD+, 36% lower; effect of pGDM, p = 0.03), increased VLDL apoB pool size (pGDM+/NAFLD-, 3.1-fold higher; pGDM+/NAFLD+, 1.2-fold higher; effect of pGDM, p = 0.02) and, at borderline significance (p = 0.05), increased rate of VLDL apoB synthesis. CONCLUSIONS/ INTERPRETATION: pGDM is associated with increased IHCL independently of adiposity. The increased liver fat contributes to the phenotype, but pGDM status is independently associated with diminished insulin secretion and (shown for the first time) augmented VLDL metabolism. IHCL with pGDM may compound a dysmetabolic phenotype.
AIMS/HYPOTHESIS: We have previously reported a high prevalence of non-alcoholic fatty liver disease (NAFLD) among women with previous gestational diabetes mellitus (pGDM). We wanted to confirm that intrahepatocellular lipid (IHCL) is associated with pGDM independently of adiposity and determine: (1) if VLDL metabolism is dysregulated; and (2) the extent to which NAFLD and IHCL account for the dysmetabolic phenotype in pGDM. METHODS: We analysed data from a cohort of 234 women (114 with pGDM) and identified effects of pGDM on lipid and glucoregulation that were independent of ultrasound-diagnosed NAFLD. We then measured IHCL by MR spectroscopy in a representative subgroup (n = 36) and conducted detailed metabolic studies (IVGTT, VLDL apolipoprotein B [apoB] kinetics and palmitate turnover) and measurement of regional body fat by MRI to demonstrate effects of IHCL that were independent of a history of pGDM. RESULTS:pGDM was associated with increased IHCL (p = 0.04) after adjustment for adiposity. Independently of IHCL, pGDM was associated with a lower IVGTT disposition index (p = 0.02) and acute insulin response to glucose (pGDM+/NAFLD-, 50% lower; pGDM+/NAFLD+, 36% lower; effect of pGDM, p = 0.03), increased VLDL apoB pool size (pGDM+/NAFLD-, 3.1-fold higher; pGDM+/NAFLD+, 1.2-fold higher; effect of pGDM, p = 0.02) and, at borderline significance (p = 0.05), increased rate of VLDL apoB synthesis. CONCLUSIONS/ INTERPRETATION:pGDM is associated with increased IHCL independently of adiposity. The increased liver fat contributes to the phenotype, but pGDM status is independently associated with diminished insulin secretion and (shown for the first time) augmented VLDL metabolism. IHCL with pGDM may compound a dysmetabolic phenotype.
Authors: Tara Kearney; Carmen Navas de Gallegos; Anthony Proudler; Kim Parker; Victor Anayaoku; Peter Bannister; Soundararajan Venkatesan; Desmond G Johnston Journal: Metabolism Date: 2003-01 Impact factor: 8.694
Authors: Soo Heon Kwak; Sung Hee Choi; Hye Seung Jung; Young Min Cho; Soo Lim; Nam H Cho; Seong Yeon Kim; Kyong Soo Park; Hak C Jang Journal: J Clin Endocrinol Metab Date: 2013-03-07 Impact factor: 5.958
Authors: Carlos Lorenzo; Lynne E Wagenknecht; Marian J Rewers; Andrew J Karter; Richard N Bergman; Anthony J G Hanley; Steven M Haffner Journal: Diabetes Care Date: 2010-09 Impact factor: 17.152
Authors: Signe Foghsgaard; Louise Vedtofte; Camilla Andreasen; Emilie S Andersen; Emilie Bahne; Jonatan I Bagger; Jens A Svare; Jens J Holst; Tine D Clausen; Elisabeth R Mathiesen; Peter Damm; Filip K Knop; Tina Vilsbøll Journal: Diabetologia Date: 2017-03-31 Impact factor: 10.122
Authors: Sarah R Donnelly; Stefanie N Hinkle; Shristi Rawal; Louise G Grunnet; Jorge E Chavarro; Allan Vaag; Jing Wu; Peter Damm; James L Mills; Mengying Li; Anne A Bjerregaard; Anne Cathrine B Thuesen; Robert E Gore-Langton; Ellen C Francis; Sylvia H Ley; Frank B Hu; Michael Y Tsai; Sjurdur F Olsen; Cuilin Zhang Journal: J Diabetes Date: 2019-06-12 Impact factor: 4.006
Authors: Kenneth Hodson; Chiara Dalla Man; Fiona E Smith; Alison Barnes; Catherine McParlin; Claudio Cobelli; Stephen C Robson; Vera Araújo-Soares; Roy Taylor Journal: Diabetologia Date: 2016-11-05 Impact factor: 10.122
Authors: Shareen Forbes; Sarah M Barr; Rebecca M Reynolds; Scott Semple; Calum Gray; Ruth Andrew; Fiona C Denison; Brian R Walker; Jane E Norman Journal: Diabetologia Date: 2015-08-07 Impact factor: 10.122